Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 2/20 | 0.62 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.61 |
| ▸ | TSHR | P16473 | 2/20 | 0.50 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.50 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.50 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.50 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.50 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.49 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.49 |
| ▸ | NPC1 | O15118 | 2/20 | 0.46 |
| ▸ | RAB9A | P51151 | 2/20 | 0.46 |
| ▸ | ESR1 | P03372 | 1/20 | 0.46 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.46 |
| ▸ | F2 | P00734 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2708103 | 0.91 | TSHR (0.52) | LMNATDP1TSHRMAPK1SLC6A2 | |
| SCHEMBL21986662 | 0.90 | TDP1 (0.68) | LMNATDP1TSHRMAPK1HIF1A | |
| SCHEMBL21986682 | 0.88 | TDP1 (0.71) | LMNATDP1TSHRMAPK1HIF1A | |
| SCHEMBL7557139 | 0.85 | LMNA (0.67) | LMNATDP1TSHRMAPK1HIF1A | |
| SCHEMBL17231745 | 0.84 | ESR1 (0.64) | LMNATDP1TSHRMAPK1SLC6A2 | |
| SCHEMBL28716635 | 0.84 | ALDH1A1 (0.61) | LMNATDP1TSHRMAPK1HIF1A | |
| SCHEMBL13360685 | 0.83 | LMNA (0.56) | LMNATDP1TSHRMAPK1HIF1A | |
| SCHEMBL4951087 | 0.83 | L3MBTL1 (0.47) | LMNATDP1TSHRKMT2ASMN1; SMN2 | |
| SCHEMBL13283577 | 0.83 | MAPT (0.53) | LMNATDP1MAPK1SMN1; SMN2ALDH1A1 | |
| SCHEMBL28777752 | 0.82 | LMNA (0.62) | LMNATDP1TSHRMAPK1HIF1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 28 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250212873-A1 | VOLATILE HDAC INHIBITORS FOR THERAPEUTIC AND PLANT APPLICATIONS | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2025-07-03 | — | — | US | claimed |
| EP-4482306-A1 | VOLATILE HDAC INHIBITORS FOR THERAPEUTIC AND PLANT APPLICATIONS | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2025-01-01 | — | — | EP | claimed |
| WO-2023192424-A1 | VOLATILE HD AC INHIBITORS FOR THERAPEUTIC AND PLANT APPLICATIONS CROSS-REFERENCE TO RELATED APPLICATION | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2023-10-05 | — | — | WO | claimed |
| US-3954842-A | FROM OLEFINS AND FORMALDEHYDE IN A SATURATED ESTER SOLVENT | PHILLIPS PETROLEUM COMPANY (US) | 1976-05-04 | — | — | US | claimed |
| US-20250212873-A1 | VOLATILE HDAC INHIBITORS FOR THERAPEUTIC AND PLANT APPLICATIONS | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2025-07-03 | — | — | US | disclosed |
| EP-4482306-A1 | VOLATILE HDAC INHIBITORS FOR THERAPEUTIC AND PLANT APPLICATIONS | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2025-01-01 | — | — | EP | disclosed |
| WO-2023192424-A1 | VOLATILE HD AC INHIBITORS FOR THERAPEUTIC AND PLANT APPLICATIONS CROSS-REFERENCE TO RELATED APPLICATION | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2023-10-05 | — | — | WO | disclosed |
| US-11655360-B2 | Gas-barrier resin composition and use thereof | SHOWA DENKO K.K. (JP) | 2023-05-23 | — | — | US | disclosed |
| CN-110799600-B | Gas barrier resin composition and use thereof | 昭和电工株式会社 | 2022-06-21 | — | — | CN | disclosed |
| US-20210275998-A1 | CATALYSTS, METHODS OF MAKING, AND METHODS OF HYDROFLUORINATION | UNIVERSITY OF LOUISVILLE RESEARCH FOUNDATION, INC. (US) | 2021-09-09 | — | — | US | disclosed |
| US-20210147669-A1 | GAS-BARRIER RESIN COMPOSITION AND USE THEREOF | SHOWA DENKO K.K. (JP) | 2021-05-20 | — | — | US | disclosed |
| US-10702858-B2 | Methods of hydrofluorination | UNIVERSITY OF LOUISVILLE RESEARCH FOUNDATION, INC. (US) | 2020-07-07 | — | — | US | disclosed |
| US-20100204184-A1 | Phosphonates useful as modulators of T-gamma-9-delta-2 activity | LABORATOIRES MAYOLY SPINDLER (FR) | 2010-08-12 | — | — | US | disclosed |
| US-20100204184-A1 | Phosphonates useful as modulators of T-gamma-9-delta-2 activity | LABORATOIRES MAYOLY SPINDLER (FR) | 2010-08-12 | — | — | US | disclosed |
| US-20100204184-A1 | Phosphonates useful as modulators of T-gamma-9-delta-2 activity | LABORATOIRES MAYOLY SPINDLER (FR) | 2010-08-12 | — | — | US | disclosed |
| US-20060241087-A1 | Phosphonates useful as modulators of t $g(g)9$g(d)2 lymphocyte activity | MONTERO JEAN-LOUIS | 2006-10-26 | — | — | US | disclosed |
| EP-0302406-B1 | Novel alternate copolymers | KURARAY CO (JP) | 1994-10-05 | — | — | EP | disclosed |
| US-4814425-A | ISOPENTENYL COMPOUNDS | KURARAY CO., LTD. (JP) | 1989-03-21 | — | — | US | disclosed |
| EP-0302406-A2 | Novel alternate copolymers | KURARAY CO., LTD. (JP) | 1989-02-08 | — | — | EP | disclosed |
| US-3954842-A | FROM OLEFINS AND FORMALDEHYDE IN A SATURATED ESTER SOLVENT | PHILLIPS PETROLEUM COMPANY (US) | 1976-05-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100204184-A1 | Phosphonates useful as modulators of T-gamma-9-delta-2 activity | CD4, PRKCD, PRKCZ | LMNA 2695/4885TDP1 2298/4885TSHR 1416/4885 |
| US-20210275998-A1 | CATALYSTS, METHODS OF MAKING, AND METHODS OF HYDROFLUORINATION | FLI1, EWSR1, KRAS | LMNA 1502/4885TDP1 1149/4885TSHR 4796/4885 |
| US-10702858-B2 | Methods of hydrofluorination | FLI1, INF2, EWSR1 | LMNA 1692/4885TDP1 1596/4885TSHR 4722/4885 |
| US-20060241087-A1 | Phosphonates useful as modulators of t $g(g)9$g(d)2 lymphocyte activity | CD4, GNG2, PLCG2 | LMNA 3304/4885TDP1 2214/4885TSHR 2353/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.